Pontine Glioma Drug Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027

The global pontine glioma drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pontine glioma is a rare, fast-growing tumor that forms in glial cells in a part of the brain stem called the pons. Additionally, diffuse intrinsic pontine gliomas tend to spread to nearby tissue and other parts of the brain stem. Further, they are hard to treat and have a poor prognosis and usually occur in children. The major factor driving the demand for the global pontine glioma drug market during the forecast period is the increasing prevalence of pontine glioma across the globe.

According to the DIPG Organization, diffuse intrinsic pontine gliomas (DIPG) are the most common brainstem tumors in children accounting for approximately 75-80% of all pediatric brainstem tumors. Additionally, approximately 150-300 patients are diagnosed with DIPG per year in the US. Moreover, approximately 6-7 years old is the median age of patients with DIPG and affects males/females in an equal ratio is 1:1. Hence, the increasing prevalence of pontine glioma is driving the demand for pontine glioma drugs which in turn is driving the growth of the market.

To Request a Sample of our Report on Pontine Glioma Drug Market: https://www.omrglobal.com/request-sample/pontine-glioma-drug-market

Some major players in the market include Oblato, Inc., and Sanofi SA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2021, Oblato, Inc. announced that it has received the granting of fast track designation from the FDA for OKN-007. It is the proprietary drug for Diffuse Intrinsic Pontine Glioma (DIPG).

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

• By Classification

• By Application

Regions Covered-

• North America

• Europe

• Asia-Pacific

• Rest of the World

Competitive Landscape- Oblato, Inc., and Sanofi SA, among others.

(Get 15% Discount on Buying this Report)

A full Report of Pontine Glioma Drug Market is Available @ https://www.omrglobal.com/industry-reports/pontine-glioma-drug-market

Global Pontine Glioma Drug Market Report by Segment

By Classification

• Diffuse Brain Stem Glioma

• Focal Brain Stem Glioma

• Recurrent Brain Stem Glioma

By Application

• Cancer Research Institutes

• Diagnostic Laboratories

• Hospitals

• Others

Global Pontine Glioma Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.